UNSPSC 51281607: Gentamicin

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H43N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T6Z9V48IKG, more generally known as gentamicin. European Medicines Agency schedules gentamicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02326MIG. The term GENTAMICIN is an International Non-Proprietary Name or INN. GENTAMICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule gentamicin under HS 29419000 and SITC 54139. As of Q4 2014, GENTAMICIN remains the US FDA Preferred Term for this commodity. Gentamicin bears US NLM identifiers UMLS ID C0017436 and NCI Concept Code C519. SMILES: CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.*.

UNSPSC 51281607 Gentamicin, a Commodity code, shows limited recent state and local activity directly aligned with its nominal scope. The two most recent opportunities posted under this code involve pharmaceutical procurement, but neither solicitation actually concerns gentamicin. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—both antibiotics distinct from gentamicin—with a total award of $2,999,999.11 over three years including renewals. Seminole County, Florida released a competitive bid for Naloxone and Safe Drug Deactivation Systems in June 2026, a public health procurement unrelated to injectable aminoglycoside antibiotics. The code appears to capture miscellaneous pharmaceutical activity rather than gentamicin specifically, suggesting that state and local procurement offices may not consistently apply this Commodity code to targeted antibiotic procurement or that gentamicin solicitations are rare enough that recent postings reflect broader categorical tagging.

The geographic spread of recent activity is limited to Illinois and Florida. State departments and county health and community service organizations are the issuing bodies visible in the data. The Illinois contract closed in August 2026 as an award under an Invitation for Bid process; the Seminole County solicitation posted June 30, 2026 with a response deadline of July 26, 2026. Neither opportunity directly supports business development targeting gentamicin supply specifically. Firms pursuing this Commodity code should verify actual demand for gentamicin products through state and local pharmacy benefit managers, public health departments, and hospital systems rather than relying on the code's tagging consistency.